IMUGENE LIMITED - Announcements

0.00%

1.5¢

Market Cap $112.0M

Healthcare Biotechnology

Imugene Limited is a clinical-stage immune-oncology company. It is engaged in developing... Imugene Limited is a clinical-stage immune-oncology company. It is engaged in developing a range of new and novel immunotherapies that seek to activate the immune system of cancer patients to treat and eradicate tumors. Its platform technology seeks to harness and promote the body’s immune system against cancerous tumors. Its product pipeline includes an off-the-shelf (allogeneic) cell therapy CAR T drug Azer-Cel (azercabtagene zapreleucel) which targets CD19 to attack blood cancer. Its pipeline includes an Oncolytic Virus and B-Cell Immunotherapies aimed at treating a variety of cancers in combination with standard of care drugs and immunotherapies. Its lead candidate is a chimeric vaccinia (pox) virus known as CF33, which is a combination of genomic sequences from multiple vaccinia virus strains to generate a new, safer and more potent virus. Its Chimeric antigen receptor (CAR)-engineered T cells (CAR T) are T cells redirected against tumors through engineered expression of CARs. More

Race Oncology (ASX: RAC) is an ASX-listed clinical stage biopharmaceutical company with a dedicated mission to be at the heart of cancer care. WEBINAR: What investors should know about what it takes for ASX-listed companies to get medical developments...

Announcements

Filter Results

All Price Sensitive Only

IMU	Application for quotation of securities - IMU		09/09/21	27.45KB	Share
IMU	Proposed issue of securities - IMU		07/09/21	25.37KB	Share
IMU	Results of Meeting		07/09/21	131.15KB	Share
IMU	S&P DJI Announces September 2021 Quarterly Rebalance	PRICE SENSITIVE	03/09/21	108.28KB	Share
IMU	Application for quotation of securities - IMU		03/09/21	29.07KB	Share
IMU	Imugene HER-Vaxx Phase 2 PFS Data and Flags Three New Trials	PRICE SENSITIVE	01/09/21	151.61KB	Share
IMU	Appendix 4E and Full Year Statutory Accounts	PRICE SENSITIVE	30/08/21	1.95MB	Share
IMU	Application for quotation of securities - IMU		27/08/21	29.19KB	Share
IMU	Phase 1 Clinical Trial Update of Immunotherapy PD1-Vaxx	PRICE SENSITIVE	27/08/21	141.61KB	Share
IMU	Response to ASX Query	PRICE SENSITIVE	23/08/21	242.77KB	Share
IMU	Appendix 2A		20/08/21	428.56KB	Share
IMU	Results of Share Purchase Plan		19/08/21	140.4KB	Share
IMU	Application for quotation of securities - IMU		13/08/21	28.31KB	Share
IMU	Further Information on Partnership with Celularity		10/08/21	120.27KB	Share
IMU	Notice of Extraordinary General Meeting/Proxy Form		06/08/21	477.36KB	Share
IMU	Imugene Investor Webinar with Celularity Dr Robert Hariri		05/08/21	117.89KB	Share
IMU	Investor Presentation		05/08/21	1.59MB	Share
IMU	Research partnership with Celularity for solid tumors	PRICE SENSITIVE	05/08/21	205.02KB	Share
IMU	Notice Under Section 708A		04/08/21	153.29KB	Share
IMU	Application for quotation of securities - IMU		04/08/21	25.72KB	Share
IMU	Imugene to present at NWR virtual investor conference		02/08/21	138.53KB	Share
IMU	Prospectus for SPP and Placement Options Offer	PRICE SENSITIVE	29/07/21	462.85KB	Share
IMU	Proposed issue of securities - IMU		29/07/21	32.93KB	Share
IMU	Proposed issue of securities - IMU		29/07/21	28.36KB	Share
IMU	Imugene Capital Raising Presentation		29/07/21	3.03MB	Share
IMU	Imugene completes $90 M placement and launches $5 M SPP	PRICE SENSITIVE	29/07/21	171.33KB	Share
IMU	Investor Webinar		28/07/21	118.4KB	Share
IMU	Trading Halt	PRICE SENSITIVE	27/07/21	179.35KB	Share
IMU	Application for quotation of securities - IMU		26/07/21	28.32KB	Share
IMU	Appendix 4C - Quarterly Report	PRICE SENSITIVE	23/07/21	404.23KB	Share
IMU	Notice Under Section 708A		09/07/21	153.32KB	Share
IMU	Application for quotation of securities - IMU		09/07/21	28.31KB	Share
IMU	Appendix 2A		09/07/21	348.38KB	Share
IMU	Proposed issue of securities - IMU		09/07/21	25.63KB	Share
IMU	Issuance of Milestone Shares Under Vaxinia Acquisition		09/07/21	140.92KB	Share
IMU	Change of Director's Interest Notice - LR		05/07/21	305.48KB	Share
IMU	Imugene Presents HER-Vaxx Update at ESMO World GI Congress		05/07/21	169.58KB	Share
IMU	FDA IND APPROVAL OF NEW ONCOLYTIC VIROTHERAPY CHECKVACC	PRICE SENSITIVE	02/07/21	133.12KB	Share
IMU	Application for quotation of securities - IMU		29/06/21	30.36KB	Share
IMU	Application for quotation of securities - IMU		25/06/21	28.31KB	Share
IMU	Notice Under Section 708A		15/06/21	153.52KB	Share
IMU	Application for quotation of securities - IMU		15/06/21	27.1KB	Share
IMU	Notification regarding unquoted securities - IMU		15/06/21	28.67KB	Share
IMU	Proposed issue of securities - IMU		11/06/21	28.75KB	Share
IMU	Investor Presentation		11/06/21	3.15MB	Share
IMU	Investor Webinar Presentation Clarification		11/06/21	142.45KB	Share
IMU	Investor Webinar Presentation		11/06/21	143.74KB	Share
IMU	Imugene Appoints Dr Monil Shah as Chief Business Officer		10/06/21	146.5KB	Share
IMU	Appendix 2A		04/06/21	381.52KB	Share
IMU	Proposed issue of Securities - IMU		04/06/21	25.23KB	Share
IMU	Change of Director's Interest Notice - LC		28/05/21	171.29KB	Share
IMU	Appendix 2A		28/05/21	374.8KB	Share
IMU	Proposed issue of Securities - IMU		28/05/21	26.86KB	Share
IMU	Managing Director and CEO increases shareholding in Imugene		28/05/21	156.08KB	Share
IMU	Change of Director's Interest Notice - PH		27/05/21	192.98KB	Share
IMU	Change of Director's Interest Notice - LC		25/05/21	172.76KB	Share
IMU	Change of Director's Interest Notice - CW		25/05/21	171.87KB	Share
IMU	Appendix 2A		25/05/21	379.85KB	Share
IMU	Proposed issue of Securities - IMU		25/05/21	26.85KB	Share
IMU	CEO & Executive Chairman increases IMU shareholding		25/05/21	196.12KB	Share
IMU	Appendix 2A		21/05/21	382.3KB	Share
IMU	Proposed issue of Securities - IMU		21/05/21	25.23KB	Share
IMU	Investor Webinar Details		18/05/21	98.98KB	Share
IMU	Investor Presentation	PRICE SENSITIVE	18/05/21	3.1MB	Share
IMU	IMUGENE LICENSES CAR T DIRECTED OV THERAPY FOR SOLID TUMOURS	PRICE SENSITIVE	18/05/21	150.1KB	Share
IMU	Appendix 2A		14/05/21	375.06KB	Share
IMU	Proposed issue of Securities - IMU		14/05/21	24.24KB	Share
IMU	Appendix 2A		07/05/21	381.95KB	Share
IMU	Proposed issue of Securities - IMU		07/05/21	25.22KB	Share
IMU	Appendix 2A		29/04/21	381.03KB	Share
IMU	Proposed issue of Securities - IMU		29/04/21	25.24KB	Share
IMU	Prestigious Research Journal Publish HER-Vaxx Phase 1B Data	PRICE SENSITIVE	29/04/21	124.23KB	Share
IMU	Appendix 4C - quarterly	PRICE SENSITIVE	23/04/21	329.82KB	Share
IMU	Imugene announces clinical milestone for HER-Vaxx	PRICE SENSITIVE	21/04/21	125.23KB	Share
IMU	Appendix 2A		19/04/21	382.61KB	Share
IMU	Proposed issue of Securities - IMU		19/04/21	26.85KB	Share
IMU	Imugene Oncolytic Virus Presentation at AACR 2021 Meeting	PRICE SENSITIVE	12/04/21	102.64KB	Share
IMU	Imugene HER-Vaxx Presentation at AACR 2021 Meeting	PRICE SENSITIVE	12/04/21	128KB	Share
IMU	Final Highest Dose in Phase 1 Clinical Trial of PD-VAXX	PRICE SENSITIVE	07/04/21	131.8KB	Share
IMU	Appendix 2A		01/04/21	460.69KB	Share
IMU	Proposed issue of Securities - IMU		01/04/21	26.85KB	Share
IMU	S&P DJI Announces March 2021 Quarterly Rebalance	PRICE SENSITIVE	12/03/21	183.24KB	Share
IMU	Appendix 3G		12/03/21	380.55KB	Share
IMU	Imugene to Present Oncolytic Virus Data at AACR21 Meeting		11/03/21	119.41KB	Share
IMU	Imugene to Present HER-Vaxx Phase 2 Data at AACR21 Meeting	PRICE SENSITIVE	11/03/21	122.7KB	Share
IMU	Half Yearly Report and Accounts	PRICE SENSITIVE	26/02/21	6.16MB	Share
IMU	Appendix 2A		23/02/21	381.94KB	Share
IMU	Proposed issue of Securities - IMU		23/02/21	25.24KB	Share
IMU	Imugene Commences Cohort 2 Dosing in Phase 1 PD1-VAXX Trial	PRICE SENSITIVE	12/02/21	124.85KB	Share
IMU	Appendix 2A		03/02/21	382.13KB	Share
IMU	Proposed issue of Securities - IMU		03/02/21	25.24KB	Share
IMU	Appendix 4C - quarterly	PRICE SENSITIVE	29/01/21	272.19KB	Share
IMU	Appendix 2A		27/01/21	381.75KB	Share
IMU	Proposed issue of Securities - IMU		27/01/21	25.24KB	Share
IMU	Imugene Dose Escalates in PD1-VAXX Phase 1 Clinical Trial	PRICE SENSITIVE	21/01/21	126.73KB	Share
IMU	IMUGENE COMPLETES RECRUITMENT TO HER-VAXX PHASE 2 TRIALIM	PRICE SENSITIVE	07/01/21	107.46KB	Share
IMU	Change of Director's Interest Notice - LC		23/12/20	228.45KB	Share
IMU	Change of Director's Interest Notice - PH		23/12/20	350.81KB	Share
IMU	Appendix 2A		22/12/20	381.62KB	Share
IMU	Proposed issue of Securities - IMU		22/12/20	24.23KB	Share

IMU Application for quotation of securities - IMU
09/09/21		27.45KB	Share
IMU Proposed issue of securities - IMU
07/09/21		25.37KB	Share
IMU Results of Meeting
07/09/21		131.15KB	Share
IMU S&P DJI Announces September 2021 Quarterly Rebalance
03/09/21	PRICE SENSITIVE	108.28KB	Share
IMU Application for quotation of securities - IMU
03/09/21		29.07KB	Share
IMU Imugene HER-Vaxx Phase 2 PFS Data and Flags Three New Trials
01/09/21	PRICE SENSITIVE	151.61KB	Share
IMU Appendix 4E and Full Year Statutory Accounts
30/08/21	PRICE SENSITIVE	1.95MB	Share
IMU Application for quotation of securities - IMU
27/08/21		29.19KB	Share
IMU Phase 1 Clinical Trial Update of Immunotherapy PD1-Vaxx
27/08/21	PRICE SENSITIVE	141.61KB	Share
IMU Response to ASX Query
23/08/21	PRICE SENSITIVE	242.77KB	Share
IMU Appendix 2A
20/08/21		428.56KB	Share
IMU Results of Share Purchase Plan
19/08/21		140.4KB	Share
IMU Application for quotation of securities - IMU
13/08/21		28.31KB	Share
IMU Further Information on Partnership with Celularity
10/08/21		120.27KB	Share
IMU Notice of Extraordinary General Meeting/Proxy Form
06/08/21		477.36KB	Share
IMU Imugene Investor Webinar with Celularity Dr Robert Hariri
05/08/21		117.89KB	Share
IMU Investor Presentation
05/08/21		1.59MB	Share
IMU Research partnership with Celularity for solid tumors
05/08/21	PRICE SENSITIVE	205.02KB	Share
IMU Notice Under Section 708A
04/08/21		153.29KB	Share
IMU Application for quotation of securities - IMU
04/08/21		25.72KB	Share
IMU Imugene to present at NWR virtual investor conference
02/08/21		138.53KB	Share
IMU Prospectus for SPP and Placement Options Offer
29/07/21	PRICE SENSITIVE	462.85KB	Share
IMU Proposed issue of securities - IMU
29/07/21		32.93KB	Share
IMU Proposed issue of securities - IMU
29/07/21		28.36KB	Share
IMU Imugene Capital Raising Presentation
29/07/21		3.03MB	Share
IMU Imugene completes $90 M placement and launches $5 M SPP
29/07/21	PRICE SENSITIVE	171.33KB	Share
IMU Investor Webinar
28/07/21		118.4KB	Share
IMU Trading Halt
27/07/21	PRICE SENSITIVE	179.35KB	Share
IMU Application for quotation of securities - IMU
26/07/21		28.32KB	Share
IMU Appendix 4C - Quarterly Report
23/07/21	PRICE SENSITIVE	404.23KB	Share
IMU Notice Under Section 708A
09/07/21		153.32KB	Share
IMU Application for quotation of securities - IMU
09/07/21		28.31KB	Share
IMU Appendix 2A
09/07/21		348.38KB	Share
IMU Proposed issue of securities - IMU
09/07/21		25.63KB	Share
IMU Issuance of Milestone Shares Under Vaxinia Acquisition
09/07/21		140.92KB	Share
IMU Change of Director's Interest Notice - LR
05/07/21		305.48KB	Share
IMU Imugene Presents HER-Vaxx Update at ESMO World GI Congress
05/07/21		169.58KB	Share
IMU FDA IND APPROVAL OF NEW ONCOLYTIC VIROTHERAPY CHECKVACC
02/07/21	PRICE SENSITIVE	133.12KB	Share
IMU Application for quotation of securities - IMU
29/06/21		30.36KB	Share
IMU Application for quotation of securities - IMU
25/06/21		28.31KB	Share
IMU Notice Under Section 708A
15/06/21		153.52KB	Share
IMU Application for quotation of securities - IMU
15/06/21		27.1KB	Share
IMU Notification regarding unquoted securities - IMU
15/06/21		28.67KB	Share
IMU Proposed issue of securities - IMU
11/06/21		28.75KB	Share
IMU Investor Presentation
11/06/21		3.15MB	Share
IMU Investor Webinar Presentation Clarification
11/06/21		142.45KB	Share
IMU Investor Webinar Presentation
11/06/21		143.74KB	Share
IMU Imugene Appoints Dr Monil Shah as Chief Business Officer
10/06/21		146.5KB	Share
IMU Appendix 2A
04/06/21		381.52KB	Share
IMU Proposed issue of Securities - IMU
04/06/21		25.23KB	Share
IMU Change of Director's Interest Notice - LC
28/05/21		171.29KB	Share
IMU Appendix 2A
28/05/21		374.8KB	Share
IMU Proposed issue of Securities - IMU
28/05/21		26.86KB	Share
IMU Managing Director and CEO increases shareholding in Imugene
28/05/21		156.08KB	Share
IMU Change of Director's Interest Notice - PH
27/05/21		192.98KB	Share
IMU Change of Director's Interest Notice - LC
25/05/21		172.76KB	Share
IMU Change of Director's Interest Notice - CW
25/05/21		171.87KB	Share
IMU Appendix 2A
25/05/21		379.85KB	Share
IMU Proposed issue of Securities - IMU
25/05/21		26.85KB	Share
IMU CEO & Executive Chairman increases IMU shareholding
25/05/21		196.12KB	Share
IMU Appendix 2A
21/05/21		382.3KB	Share
IMU Proposed issue of Securities - IMU
21/05/21		25.23KB	Share
IMU Investor Webinar Details
18/05/21		98.98KB	Share
IMU Investor Presentation
18/05/21	PRICE SENSITIVE	3.1MB	Share
IMU IMUGENE LICENSES CAR T DIRECTED OV THERAPY FOR SOLID TUMOURS
18/05/21	PRICE SENSITIVE	150.1KB	Share
IMU Appendix 2A
14/05/21		375.06KB	Share
IMU Proposed issue of Securities - IMU
14/05/21		24.24KB	Share
IMU Appendix 2A
07/05/21		381.95KB	Share
IMU Proposed issue of Securities - IMU
07/05/21		25.22KB	Share
IMU Appendix 2A
29/04/21		381.03KB	Share
IMU Proposed issue of Securities - IMU
29/04/21		25.24KB	Share
IMU Prestigious Research Journal Publish HER-Vaxx Phase 1B Data
29/04/21	PRICE SENSITIVE	124.23KB	Share
IMU Appendix 4C - quarterly
23/04/21	PRICE SENSITIVE	329.82KB	Share
IMU Imugene announces clinical milestone for HER-Vaxx
21/04/21	PRICE SENSITIVE	125.23KB	Share
IMU Appendix 2A
19/04/21		382.61KB	Share
IMU Proposed issue of Securities - IMU
19/04/21		26.85KB	Share
IMU Imugene Oncolytic Virus Presentation at AACR 2021 Meeting
12/04/21	PRICE SENSITIVE	102.64KB	Share
IMU Imugene HER-Vaxx Presentation at AACR 2021 Meeting
12/04/21	PRICE SENSITIVE	128KB	Share
IMU Final Highest Dose in Phase 1 Clinical Trial of PD-VAXX
07/04/21	PRICE SENSITIVE	131.8KB	Share
IMU Appendix 2A
01/04/21		460.69KB	Share
IMU Proposed issue of Securities - IMU
01/04/21		26.85KB	Share
IMU S&P DJI Announces March 2021 Quarterly Rebalance
12/03/21	PRICE SENSITIVE	183.24KB	Share
IMU Appendix 3G
12/03/21		380.55KB	Share
IMU Imugene to Present Oncolytic Virus Data at AACR21 Meeting
11/03/21		119.41KB	Share
IMU Imugene to Present HER-Vaxx Phase 2 Data at AACR21 Meeting
11/03/21	PRICE SENSITIVE	122.7KB	Share
IMU Half Yearly Report and Accounts
26/02/21	PRICE SENSITIVE	6.16MB	Share
IMU Appendix 2A
23/02/21		381.94KB	Share
IMU Proposed issue of Securities - IMU
23/02/21		25.24KB	Share
IMU Imugene Commences Cohort 2 Dosing in Phase 1 PD1-VAXX Trial
12/02/21	PRICE SENSITIVE	124.85KB	Share
IMU Appendix 2A
03/02/21		382.13KB	Share
IMU Proposed issue of Securities - IMU
03/02/21		25.24KB	Share
IMU Appendix 4C - quarterly
29/01/21	PRICE SENSITIVE	272.19KB	Share
IMU Appendix 2A
27/01/21		381.75KB	Share
IMU Proposed issue of Securities - IMU
27/01/21		25.24KB	Share
IMU Imugene Dose Escalates in PD1-VAXX Phase 1 Clinical Trial
21/01/21	PRICE SENSITIVE	126.73KB	Share
IMU IMUGENE COMPLETES RECRUITMENT TO HER-VAXX PHASE 2 TRIALIM
07/01/21	PRICE SENSITIVE	107.46KB	Share
IMU Change of Director's Interest Notice - LC
23/12/20		228.45KB	Share
IMU Change of Director's Interest Notice - PH
23/12/20		350.81KB	Share
IMU Appendix 2A
22/12/20		381.62KB	Share
IMU Proposed issue of Securities - IMU
22/12/20		24.23KB	Share

REFRESH

First 3 4 5 6 7

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 1.5¢		Change 0.000(0.00%)		Mkt cap ! $112.0M

Open	High	Low	Value	Volume
1.5¢	1.6¢	1.4¢	$125.4K	8.369M

Buyers (Bids)

No.	Vol.	Price($)
76	17029463	1.4¢

Sellers (Offers)

Price($)	Vol.	No.
1.5¢	1061875	3

View Market Depth

No.	Vol.	Price($)
67	15122749	0.014
35	10959455	0.013
40	8162244	0.012
13	3263001	0.011
30	6569728	0.010

Price($)	Vol.	No.
0.015	873992	2
0.016	10695661	30
0.017	6170154	16
0.018	6533023	29
0.019	6839697	18

Last trade - 16.10pm 13/06/2025 (20 minute delay)

IMU (ASX) Chart

IMUGENE LIMITED - Announcements

Announcements

Buyers (Bids)

Sellers (Offers)

Top Stories